A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.

The ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We have previously shown that most Candida spp. can produce...

Full description

Bibliographic Details
Main Authors: Mikko T Nieminen, Lily Novak-Frazer, Wilma Rautemaa, Ranjith Rajendran, Timo Sorsa, Gordon Ramage, Paul Bowyer, Riina Rautemaa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4081779?pdf=render
id doaj-fc7cd95a82204dca83f120f250e3471c
record_format Article
spelling doaj-fc7cd95a82204dca83f120f250e3471c2020-11-25T00:18:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0197e10185910.1371/journal.pone.0101859A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.Mikko T NieminenLily Novak-FrazerWilma RautemaaRanjith RajendranTimo SorsaGordon RamagePaul BowyerRiina RautemaaThe ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We have previously shown that most Candida spp. can produce significant levels of mutagenic acetaldehyde (ACH). ACH is also an important mediator of candidal biofilm formation. We have also reported that D,L-2-hydroxyisocaproic acid (HICA) significantly inhibits planktonic growth of C. albicans. The aim of the present study was to investigate the effect of HICA on C. albicans biofilm formation and ACH production in vitro. Inhibition of biofilm formation by HICA, analogous control compounds or caspofungin was measured using XTT to measure biofilm metabolic activity and PicoGreen as a marker of biomass. Biofilms were visualised by scanning electron microscopy (SEM). ACH levels were measured by gas chromatography. Transcriptional changes in the genes involved in ACH metabolism were measured using RT-qPCR. The mean metabolic activity and biomass of all pre-grown (4, 24, 48 h) biofilms were significantly reduced after exposure to HICA (p<0.05) with the largest reductions seen at acidic pH. Caspofungin was mainly active against biofilms pre-grown for 4 h at neutral pH. Mutagenic levels (>40 μM) of ACH were detected in 24 and 48 h biofilms at both pHs. Interestingly, no ACH production was detected from D-glucose in the presence of HICA at acidic pH (p<0.05). Expression of genes responsible for ACH catabolism was up-regulated by HICA but down-regulated by caspofungin. SEM showed aberrant hyphae and collapsed hyphal structures during incubation with HICA at acidic pH. We conclude that HICA has potential as an antifungal agent with ability to inhibit C. albicans cell growth and biofilm formation. HICA also significantly reduces the mutagenic potential of C. albicans biofilms, which may be important when treating bacterial-fungal biofilm infections.http://europepmc.org/articles/PMC4081779?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Mikko T Nieminen
Lily Novak-Frazer
Wilma Rautemaa
Ranjith Rajendran
Timo Sorsa
Gordon Ramage
Paul Bowyer
Riina Rautemaa
spellingShingle Mikko T Nieminen
Lily Novak-Frazer
Wilma Rautemaa
Ranjith Rajendran
Timo Sorsa
Gordon Ramage
Paul Bowyer
Riina Rautemaa
A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
PLoS ONE
author_facet Mikko T Nieminen
Lily Novak-Frazer
Wilma Rautemaa
Ranjith Rajendran
Timo Sorsa
Gordon Ramage
Paul Bowyer
Riina Rautemaa
author_sort Mikko T Nieminen
title A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
title_short A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
title_full A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
title_fullStr A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
title_full_unstemmed A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
title_sort novel antifungal is active against candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We have previously shown that most Candida spp. can produce significant levels of mutagenic acetaldehyde (ACH). ACH is also an important mediator of candidal biofilm formation. We have also reported that D,L-2-hydroxyisocaproic acid (HICA) significantly inhibits planktonic growth of C. albicans. The aim of the present study was to investigate the effect of HICA on C. albicans biofilm formation and ACH production in vitro. Inhibition of biofilm formation by HICA, analogous control compounds or caspofungin was measured using XTT to measure biofilm metabolic activity and PicoGreen as a marker of biomass. Biofilms were visualised by scanning electron microscopy (SEM). ACH levels were measured by gas chromatography. Transcriptional changes in the genes involved in ACH metabolism were measured using RT-qPCR. The mean metabolic activity and biomass of all pre-grown (4, 24, 48 h) biofilms were significantly reduced after exposure to HICA (p<0.05) with the largest reductions seen at acidic pH. Caspofungin was mainly active against biofilms pre-grown for 4 h at neutral pH. Mutagenic levels (>40 μM) of ACH were detected in 24 and 48 h biofilms at both pHs. Interestingly, no ACH production was detected from D-glucose in the presence of HICA at acidic pH (p<0.05). Expression of genes responsible for ACH catabolism was up-regulated by HICA but down-regulated by caspofungin. SEM showed aberrant hyphae and collapsed hyphal structures during incubation with HICA at acidic pH. We conclude that HICA has potential as an antifungal agent with ability to inhibit C. albicans cell growth and biofilm formation. HICA also significantly reduces the mutagenic potential of C. albicans biofilms, which may be important when treating bacterial-fungal biofilm infections.
url http://europepmc.org/articles/PMC4081779?pdf=render
work_keys_str_mv AT mikkotnieminen anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT lilynovakfrazer anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT wilmarautemaa anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT ranjithrajendran anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT timosorsa anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT gordonramage anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT paulbowyer anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT riinarautemaa anovelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT mikkotnieminen novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT lilynovakfrazer novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT wilmarautemaa novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT ranjithrajendran novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT timosorsa novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT gordonramage novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT paulbowyer novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
AT riinarautemaa novelantifungalisactiveagainstcandidaalbicansbiofilmsandinhibitsmutagenicacetaldehydeproductioninvitro
_version_ 1725377112292982784